KUALA LUMPUR, June 25 -- ADX Labs Inc (ADX) via its charitable arm, ADX Foundation has donated US$100,000 to the Coalition for Epidemic Preparedness Innovations (CEPI) to accelerate COVID-19 vaccine development. (US$1 = RM4.276)
According to a statement, to date, CEPI has funded a diverse portfolio of nine vaccine candidates against COVID-19, with the ambition of developing a safe, effective and globally accessible vaccine within a 12-18-month time-frame.
To increase their chances of success, CEPI also opened a new funding opportunity recently, focusing on additional vaccine candidates that have the potential to be developed rapidly and manufactured globally at scale.
ADX founder and chief executive officer (CEO) and ADX Foundation chairman, Steven M. Renner said: “CEPI’s new Call for Proposals to accelerate vaccine candidates against COVID-19 is a highly promising initiative, and ADX Labs is proud to help CEPI’s vaccine development partners increase their chances of success.”
According to CEPI CEO, Dr Richard Hatchett, investment in vaccines and other scientific innovations is now crucial to give the best possible chance of ending this pandemic.
ADX independently funds the ADX Foundation, a registered non-profit philanthropic organisation which has invested in children, communities and social justice since 2013.
-- BERNAMA
No comments:
Post a Comment